Paradice Investment Management LLC Has $46.92 Million Stock Holdings in Encompass Health Co. (NYSE:EHC)
Paradice Investment Management LLC Has $46.92 Million Stock Holdings in Encompass Health Co. (NYSE:EHC)
Paradice Investment Management LLC boosted its stake in shares of Encompass Health Co. (NYSE:EHC – Get Rating) by 25.6% in the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 837,107 shares of the company's stock after purchasing an additional 170,703 shares during the period. Encompass Health comprises approximately 3.6% of Paradice Investment Management LLC's investment portfolio, making the stock its 10th biggest holding. Paradice Investment Management LLC's holdings in Encompass Health were worth $46,920,000 as of its most recent SEC filing.
据Holdings Channel.com报道，Paradice Investment Management LLC在第二季度增持了Enfinass Health Co.(纽约证券交易所代码：EHC-GET Rating)的股份25.6%。该机构投资者持有该公司837,107股股票，在此期间又购买了170,703股。Encludass Health约占Paradice Investment Management LLC投资组合的3.6%，使该股成为其第10大持股。截至最近提交给美国证券交易委员会的文件，Paradice Investment Management LLC持有的Enundass Health股份价值46,920,000美元。
Several other institutional investors also recently added to or reduced their stakes in the stock. Leeward Investments LLC MA grew its position in Encompass Health by 68.1% during the second quarter. Leeward Investments LLC MA now owns 392,444 shares of the company's stock valued at $21,996,000 after buying an additional 159,030 shares during the period. FNY Investment Advisers LLC bought a new position in Encompass Health during the second quarter worth about $2,317,000. Wedge Capital Management L L P NC boosted its position in Encompass Health by 7.7% during the second quarter. Wedge Capital Management L L P NC now owns 706,572 shares of the company's stock worth $39,603,000 after purchasing an additional 50,689 shares during the period. Brookstone Capital Management boosted its position in Encompass Health by 19.3% during the second quarter. Brookstone Capital Management now owns 11,245 shares of the company's stock worth $544,000 after purchasing an additional 1,821 shares during the period. Finally, Bank of America Corp DE boosted its position in Encompass Health by 1.5% during the first quarter. Bank of America Corp DE now owns 251,111 shares of the company's stock worth $17,856,000 after purchasing an additional 3,660 shares during the period. Institutional investors own 93.07% of the company's stock.
其他几家机构投资者最近也增持或减持了该股。Leeward Investments LLC MA在第二季度将其在Enneass Health的头寸增加了68.1%。Leeward Investments LLC MA现在拥有该公司392,444股股票，价值21,996,000美元，在此期间又购买了159,030股。FNY投资顾问有限责任公司在第二季度购买了一个价值约2,317,000美元的新头寸。韦奇资本管理公司L L P NC在第二季度将其在Enneass Health的头寸提高了7.7%。在此期间，韦奇资本管理公司购买了50,689股，现在拥有706,572股公司股票，价值39,603,000美元。Brookstone Capital Management在第二季度将其在Enneass Health的头寸提高了19.3%。Brookstone Capital Management现在拥有11,245股该公司股票，价值544,000美元，在此期间又购买了1,821股。最后，美国银行DE在第一季度将其在Enneass Health的头寸提高了1.5%。美国银行DE目前持有251,111股该公司股票，价值17,856,000美元，在此期间又购买了3,660股。机构投资者持有该公司93.07%的股票。
Wall Street Analyst Weigh In
华尔街分析师也加入进来
EHC has been the subject of a number of research reports. Raymond James cut their target price on shares of Encompass Health from $70.00 to $65.00 and set a "strong-buy" rating for the company in a research report on Thursday, August 4th. BMO Capital Markets cut their target price on shares of Encompass Health from $83.00 to $65.00 and set an "outperform" rating for the company in a research report on Thursday, August 4th. Barclays cut their target price on shares of Encompass Health from $80.00 to $63.00 and set an "overweight" rating for the company in a research report on Thursday, August 4th. StockNews.com lowered shares of Encompass Health from a "buy" rating to a "hold" rating in a research report on Wednesday, August 3rd. Finally, Credit Suisse Group cut their price objective on shares of Encompass Health from $63.00 to $62.00 and set an "outperform" rating for the company in a research report on Wednesday, September 21st. One research analyst has rated the stock with a hold rating, seven have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, Encompass Health presently has a consensus rating of "Buy" and a consensus target price of $66.89.
EHC已经成为许多研究报告的主题。雷蒙德·詹姆斯在8月4日周四的一份研究报告中将Enneass Health的目标价从70.00美元下调至65.00美元，并将该公司的评级定为“强力买入”。BMO Capital Markets在8月4日(星期四)的一份研究报告中将Enneass Health的目标价从83.00美元下调至65.00美元，并为该公司设定了“跑赢大盘”的评级。巴克莱在8月4日周四的一份研究报告中将Enneass Health的目标价从80.00美元下调至63.00美元，并为该公司设定了“增持”评级。在8月3日星期三的一份研究报告中，StockNews.com将Enneass Health的股票评级从“买入”下调至“持有”。最后，瑞士信贷集团在9月21日星期三的一份研究报告中将Enneass Health的股票目标价从63.00美元下调至62.00美元，并为该公司设定了“表现优于大盘”的评级。一位研究分析师对该股的评级为持有，7位分析师给出了买入评级，一位分析师对该公司发出了强烈的买入评级。根据MarketBeat的数据，Enoverass Health目前的共识评级为“买入”，共识目标价为66.89美元。
Encompass Health Price Performance
涵盖健康性价比
Encompass Health (NYSE:EHC – Get Rating) last announced its earnings results on Monday, August 1st. The company reported $0.89 earnings per share for the quarter, missing analysts' consensus estimates of $0.97 by ($0.08). The company had revenue of $1.33 billion during the quarter, compared to analysts' expectations of $1.34 billion. Encompass Health had a net margin of 6.22% and a return on equity of 16.20%. The company's revenue for the quarter was up 3.3% compared to the same quarter last year. During the same period in the prior year, the business earned $1.17 earnings per share. On average, equities research analysts predict that Encompass Health Co. will post 2.88 EPS for the current year.
Enfinass Health(纽约证券交易所代码：EHC-GET Rating)最近一次公布收益结果是在8月1日星期一。该公司公布本季度每股收益为0.89美元，低于分析师普遍预期的0.97美元(0.08美元)。该公司本季度营收为13.3亿美元，高于分析师预期的13.4亿美元。Encludass Health的净利润率为6.22%，股本回报率为16.20%。与去年同期相比，该公司本季度的收入增长了3.3%。去年同期，该业务每股收益为1.17美元。平均而言，股票研究公司分析师预测，Enneass Health Co.本年度每股收益将达到2.88欧元。
Encompass Health Cuts Dividend
包括削减股息的医疗保健
The business also recently announced a quarterly dividend, which will be paid on Monday, October 17th. Investors of record on Monday, October 3rd will be paid a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a yield of 1.29%. The ex-dividend date of this dividend is Friday, September 30th. Encompass Health's dividend payout ratio is currently 34.25%.
该公司最近还宣布了季度股息，将于10月17日(星期一)支付。10月3日(星期一)登记在册的投资者将获得0.15美元的股息。这意味着年化股息为0.60美元，收益率为1.29%。本次股息除息日为9月30日(星期五)。Enneass Health的股息支付率目前为34.25%。
Insider Activity at Encompass Health
Enneass Health的内部活动
In related news, CEO Mark J. Tarr sold 20,449 shares of the firm's stock in a transaction that occurred on Wednesday, August 17th. The shares were sold at an average price of $53.25, for a total value of $1,088,909.25. Following the sale, the chief executive officer now directly owns 440,895 shares of the company's stock, valued at $23,477,658.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 2.70% of the stock is currently owned by insiders.
在相关新闻中，首席执行官马克·J·塔尔在8月17日星期三的一次交易中出售了20,449股公司股票。这些股票的平均价格为53.25美元，总价值为1,088,909.25美元。出售后，这位首席执行官现在直接持有440,895股公司股票，价值23,477,658.75美元。这笔交易是在提交给美国证券交易委员会的一份法律文件中披露的，该文件可在美国证券交易委员会网站。目前该公司2.70%的股份由内部人士持有。
About Encompass Health
关于包罗万象健康
(Get Rating)
(获取评级)
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
Enneass Health Corporation在美国提供基于设施和以家庭为基础的急性后保健服务。该公司在两个领域开展业务，住院康复以及家庭健康和临终关怀。住院康复部分为正在康复的患者提供住院和门诊的专门康复治疗，这些疾病包括中风和其他神经疾病、心脏和肺部疾病、脑和脊髓损伤、复杂的骨科疾病和截肢。
Featured Articles
专题文章
- Get a free copy of the StockNews.com research report on Encompass Health (EHC)
- Build A Better Tech Portfolio With Jabil Inc.
- Autodesk Is A Mature Company Still Acting Like A Growth Stock
- Is There Value In These Growth Stocks?
- MarketBeat Podcast, 3 Stocks to Watch Newmont Mining, Walmart, AMC
- MO Money: Why Altria Group Stock is Rallying
- 免费获取StockNews.com关于Enfass Health(EHC)的研究报告
- 与捷普公司一起打造更好的技术产品组合。
- 欧特克是一家成熟的公司，仍是一只成长型股票
- 这些成长型股票有价值吗？
- MarketBeat Podcast，3只股票关注纽蒙特矿业、沃尔玛、AMC
- Mo Money：奥驰亚集团股价为何上涨
Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Co. (NYSE:EHC – Get Rating).
想看看其他对冲基金持有EHC吗？请访问HoldingsChannel.com，获取Enneass Health Co.(纽约证券交易所代码：EHC-GET Rating)的最新13F申报文件和内幕交易信息。
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.
接受《包罗万象健康日报》的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯，接收最新新闻和分析师对Enneass Health及相关公司评级的每日简要摘要。